Prehospital Adenosine Diphosphate Receptor Blocker Use, Culprit Artery Flow, and Mortality in STEMI: The MADDEC Study.
Markus HautamäkiLeo-Pekka LyytikäinenMarkku EskolaTerho LehtimäkiKjell NikusNiku OksalaJuho TynkkynenJussi HernesniemiPublished in: Clinical drug investigation (2021)
The newer ADP receptor blockers are associated with lower mortality and better culprit artery flow at presentation when compared with clopidogrel. There are no significant differences between the two newer drugs. As the drugs were mainly used during three consecutive periods, unmeasured confounding related to the development of cardiac care and changes in the population may contribute to the results.
Keyphrases
- cardiovascular events
- percutaneous coronary intervention
- healthcare
- angiotensin converting enzyme
- acute coronary syndrome
- cardiac arrest
- risk factors
- palliative care
- left ventricular
- st segment elevation myocardial infarction
- quality improvement
- cardiovascular disease
- heart failure
- st elevation myocardial infarction
- coronary artery disease
- affordable care act